相关实验视频
Updated: Jun 27, 2025

05:56
A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
Published on: February 20, 2021
2.1K
SIRT在败血症中的作用和治疗潜力
Jiaqi You1, Yilin Li2, Wei Chong1
1Department of Emergency, The First Hospital of China Medical University, Shenyang, China.
Frontiers in immunology
|May 1, 2024
概括
赛尔图因 (SIRT) 调节免疫细胞炎症,能量代谢和氧化应激,提供潜在的败血症治疗方法. 增强SIRT活性的药物可以减少败血症患者的器官功能障碍.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 败血症涉及免疫功能障碍和代谢障碍.
- 塞尔图因 (SIRT) 在败血症的发病过程中至关重要.
- SIRT调节炎症,能量代谢和氧化应激.
研究的目的:
- 审查SIRT在败血症发病过程中的作用.
- 探索SIRT对败血症免疫细胞的影响.
- 讨论针对SIRT的药物的治疗潜力.
主要方法:
- 对SIRT和败血症研究的文献综述.
- 对SIRT对免疫细胞通路的影响的分析.
- 药物诱导的SIRT调节的检查.
主要成果:
- SIRT调节免疫细胞的炎症反应.
- SIRT可以增强线粒体功能和能量平衡.
- 通过抗氧化途径,SIRT可以减轻氧化应激.
- 复星和黑激素增强SIRT活性,显示出治疗前景.
结论:
- 赛尔特蛋白是败血症的关键调节剂.
- 向SIRT为败血症和器官功能障碍提供了一个新的治疗策略.
- 激活SIRT的药物在败血症治疗中具有潜在的临床应用.
相关概念视频
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
169
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
169

